Avaleht › Melanoom › Ohio › Columbus
Melanoom kliinilised uuringud linnas Columbus, OH
21 uuringut haiguse Melanoom jaoks otsivad osalejaid linnas Columbus ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- The Mark H Zangmeister Center, Columbus
- ja veel 8
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
VärbamineFaas 3
- The Ohio State University Wexner Medical Center, Columbus
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
VärbamineFaas 3
- Ohio State University, Columbus
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
VärbamineFaas 3
- Ohio State University Comprehensive Cancer Center, Columbus
Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
VärbamineFaas 1
- Ohio State University, Columbus
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
VärbamineFaas 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- ja veel 15
Project: Every Child for Younger Patients With Cancer
VärbamineVaatlusuuring
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
VärbamineFaas 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
VärbamineFaas 1
- Ohio State University Comprehensive Cancer Center, Columbus
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
VärbamineFaas 1/2
- Ohio State University Comprehensive Cancer Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
VärbamineFaas 1/2
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
Neoadjuvant Darovasertib in Primary Uveal Melanoma
VärbamineFaas 3
- Ohio State Eye and Ear Institute, Columbus
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
VärbamineFaas 2/3
- The Ohio State University, Columbus
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
VärbamineVaatlusuuring
- Memorial Hospital, Marysville · 27 mi kaugusel
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
VärbamineFaas 2
- Ohio State University Comprehensive Cancer Center, Columbus
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- The Ohio State University Wexner Medical Center, Columbus
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
VärbamineFaas 3
- The Ohio State University Comprehensive Cancer Center, Columbus
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
- Ohio State University Comprehensive Cancer Center, Columbus
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
VärbamineFaas 3
- Ohio State University Wexner Medical Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
VärbamineVaatlusuuring
- Massive Bio SYNERGY-AI site, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Värbamine
- Ohio State University Comprehensive Cancer Center, Columbus
Melanoom uuringud teistes linnades
- Houston, TX59 uuringut
- New York City, NY38 uuringut
- Los Angeles, CA34 uuringut
- Nashville, TN33 uuringut
- Pittsburgh, PA31 uuringut
- Boston, MA26 uuringut
- Philadelphia, PA23 uuringut
- San Francisco, CA22 uuringut
- Durham, NC21 uuringut
- Atlanta, GA21 uuringut
- St. Louis, MO21 uuringut
- Salt Lake City, UT21 uuringut
Muud uuringud linnas Columbus
- Mitteväikerakuline kopsuvähk56 uuringut
- Rinnavähk39 uuringut
- Munasarjavähk39 uuringut
- Vähk (kõik liigid)38 uuringut
- Kopsuvähk37 uuringut
- Äge müeloidne leukeemia35 uuringut
- Krooniline lümfotsütaarne leukeemia28 uuringut
- Metastaatiline vähk27 uuringut
- Endomeetriumivähk25 uuringut
- Käär- ja pärasoolevähk24 uuringut
- Eesnäärmevähk24 uuringut
- Müeloom24 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.